Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
62.2M
-
Shares change
-
-1.64M
-
Total reported value, excl. options
-
$249M
-
Value change
-
-$3.15M
-
Put/Call ratio
-
0.31
-
Number of buys
-
63
-
Number of sells
-
-57
-
Price
-
$4.01
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q2 2020
133 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q2 2020.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.2M shares
of 374M outstanding shares and own 16.61% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6M shares), Neuberger Berman Group LLC (5.7M shares), BlackRock Inc. (5.23M shares), Indaba Capital Management, L.P. (3.96M shares), VANGUARD GROUP INC (3.93M shares), RENAISSANCE TECHNOLOGIES LLC (3.37M shares), ORBIMED ADVISORS LLC (2.91M shares), Partner Fund Management, L.P. (1.92M shares), MILLENNIUM MANAGEMENT LLC (1.86M shares), and PARADIGM CAPITAL MANAGEMENT INC/NY (1.51M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.